Reference
Lee KJP, et al. Immunomodulating biologics and SCJD. Neurology 92 (Suppl.): abstr. P5.9-015, No. 15, 9 Apr 2019. Available from: URL: https://n.neurology.org/content/92/15_Supplement/P5.9-015 [abstract] - USA
Rights and permissions
About this article
Cite this article
Adalimumab/infliximab/vedolizumab. Reactions Weekly 1776, 20 (2019). https://doi.org/10.1007/s40278-019-70178-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-70178-3